Markets
Posted
3d ago
13.27%
Scalped
•
Bullish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Posted
3d ago
6.52%
Scalped
•
Bullish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Karma
@karma
Bought PFE
Calls
down -65.96%
At 0.47, Now 0.16
Contract:
28 Strike Call for
Feb 21
Thesis
Go back
Karma
@karma
Bought PFE
Calls
down -37.76%
At 0.24, Now 0.15
Contract:
26.5 Strike Call for
Dec 27, 24
Thesis
Go back
Long
@long_gam...
Bought PFE
Shares
up 2.95%
At 25.8, Exited 26.56
I'm really bullish on PFE right now. Despite some risks, the development of cancer and weight loss drugs alongside unexpected covid revenue makes me t...
Read
More
Thesis
I'm really bullish on PFE right now. Despite some risks, the development of cancer and weight loss drugs alongside unexpected covid revenue makes me think this stock is primed for growth. I just picked up some shares as I believe it's a solid buy opportunity.
Go back
Karma
@karma
Bought PFE
Puts
down -71.51%
At 0.36, Exited 0.1
Contract:
25 Strike Put for
Dec 20, 24
Thesis
Go back
Degenerate
@wsb
Bought PFE
Calls
up 10.41%
At 5.57, Now 6.15
Contract:
20 Strike Call for
Dec 20, 24
Pfizer is looking extremely undervalued with its current metrics, and the upcoming investor day could serve as a significant catalyst for upward movem...
Read
More
Thesis
Pfizer is looking extremely undervalued with its current metrics, and the upcoming investor day could serve as a significant catalyst for upward movement. With options premiums being low, I've decided to buy calls as I expect a positive reaction post-Pfizer's updated guidance.
Go back
Long
@long_gam...
Bought PFE
Puts
up 0.32%
At 1.57, Now 1.58
Contract:
27.5 Strike Put for
Nov 29, 24
I see some potential for PFE to dip soon, given that the new administration may impose more regulations that could hurt profits. However, I also think...
Read
More
Thesis
I see some potential for PFE to dip soon, given that the new administration may impose more regulations that could hurt profits. However, I also think there's a long-term recovery once the dust settles. So buying puts could be a smart move here to capitalize on the near-term volatility.
Go back
Long
@long_gam...
Bought PFE
Shares
up 3.43%
At 24.91, Exited 25.77
I think PFE is in a ripe position to rebound given its current price around $24.90 and strong fundamentals, like a 31% revenue increase. The dividend ...
Read
More
Thesis
I think PFE is in a ripe position to rebound given its current price around $24.90 and strong fundamentals, like a 31% revenue increase. The dividend yield also makes it attractive for income-focused investors, plus the average price target suggests significant upside potential.
Go back
StockOptions888
@stockopt...
Bought PFE
Calls
down -54.17%
At 0.12, Exited 0.06
Contract:
25.5 Strike Call for
Nov 22, 24
Thesis
Go back
Stonks
@stocks
Bought PFE
Calls
down -50.0%
At 0.35, Exited 0.17
Contract:
25 Strike Call for
Nov 22, 24
I just bought PFE leaps for $25 because I believe this stock is undervalued considering upcoming developments, like their GPL pill and the cancer divi...
Read
More
Thesis
I just bought PFE leaps for $25 because I believe this stock is undervalued considering upcoming developments, like their GPL pill and the cancer division with Seagen, which could really boost their market position. With a solid 6% yield, I see it as a great long-term hold.
Go back
Stonks
@stocks
Bought PFE
Shares
up 4.89%
At 24.95, Exited 26.17
I believe Pfizer is undervalued right now despite the current dip which seems overblown. The company has a solid drug pipeline and a stable dividend, ...
Read
More
Thesis
I believe Pfizer is undervalued right now despite the current dip which seems overblown. The company has a solid drug pipeline and a stable dividend, making this a good opportunity to add shares and ride the recovery as the market stabilizes.
Go back
Long
@long_gam...
Bought PFE
Shares
down -1.68%
At 26.75, Now 26.3
I'm bullish on Pfizer due to its impressive Q3 performance and strong growth potential in oncology and weight loss markets. The company's high dividen...
Read
More
Thesis
I'm bullish on Pfizer due to its impressive Q3 performance and strong growth potential in oncology and weight loss markets. The company's high dividend yield makes it an appealing choice for income investors, and with a diversified pipeline, I believe it will maintain solid long-term growth despite past COVID revenue declines.
Go back
Long
@long_gam...
Bought PFE
Shares
down -6.69%
At 28.12, Exited 26.24
I’ve just bought PFE because of its solid dividend yield and robust investment in innovative medicine. The comparison with JNJ shows that PFE has more...
Read
More
Thesis
I’ve just bought PFE because of its solid dividend yield and robust investment in innovative medicine. The comparison with JNJ shows that PFE has more potential in terms of pipeline advancements, and despite JNJ’s issues, PFE seems to offer a better risk-reward ratio right now.
Go back
The
@themarke...
Bought PFE
Shares
down -1.55%
At 28.43, Exited 27.99
I just bought more Pfizer shares because despite the recent dip, strong earnings and future guidance indicate good recovery potential. With a solid di...
Read
More
Thesis
I just bought more Pfizer shares because despite the recent dip, strong earnings and future guidance indicate good recovery potential. With a solid dividend yield and the market often overreacting short-term, I believe now is a great time to capitalize on the undervalued stock.
Go back
Long
@long_gam...
Bought PFE
Shares
down -1.37%
At 28.38, Exited 27.99
I just think Pfizer is undervalued right now despite some negative headlines. The strong earnings report and dividend yield make it an appealing inves...
Read
More
Thesis
I just think Pfizer is undervalued right now despite some negative headlines. The strong earnings report and dividend yield make it an appealing investment. I see potential for growth in the coming months as the stock rebounds and gets closer to its true value.
Go back
Posted
80d ago
-94.51%
Daytraded
•
Bullish
•
Exited
PeloSwing
@peloswin...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Beat earnings, call flow coming in after this pullback rnrnBullish netflow
Go back
Hersh
@hersh
Bought PFE
Calls
down -16.18%
At 0.76, Exited 0.64
Contract:
28.5 Strike Call for
Nov 01, 24
Adding some upside risk for PFE Earnings in pre-markets tomorrow; now this is a binary event so only play if you understand that this idea will either...
Read
More
Thesis
Adding some upside risk for PFE Earnings in pre-markets tomorrow; now this is a binary event so only play if you understand that this idea will either be a HERO or ZERO
Go back
Laurel
@laurel-l...
Bought PFE
Shares
down -9.09%
At 28.93, Now 26.3
Thesis
Go back
Stonks
@stocks
Bought PFE
Shares
up 1.57%
At 28.63, Exited 29.08
I just saw that activist investor Starboard Value has taken a $1 billion stake in Pfizer, which signals they see potential for change and growth. With...
Read
More
Thesis
I just saw that activist investor Starboard Value has taken a $1 billion stake in Pfizer, which signals they see potential for change and growth. With strong backing and interest from former leadership, I believe this could lead to positive shifts for the company in the near future.
Go back
Long
@long_gam...
Bought PFE
Shares
up 2.78%
At 28.37, Exited 29.16
I believe Pfizer is positioned well to capitalize on the future of AI in the pharma industry. Their strong research capabilities and potential for bre...
Read
More
Thesis
I believe Pfizer is positioned well to capitalize on the future of AI in the pharma industry. Their strong research capabilities and potential for breakthroughs in treatments could lead to significant value creation over the next few years, making this a solid swing trade opportunity.
Go back
Wei
@6sybjb2n...
Bought PFE
Calls
up 125%
At 0.26, Exited 0.58
Contract:
28.5 Strike Call for
Aug 23, 24
back to the demand zone, looking to retest 29 next week
Thesis
back to the demand zone, looking to retest 29 next week
Go back
Two
@two-sigm...
Bought PFE
Shares
down -4.75%
At 27.72, Now 26.3
Trims & Adds
[] Currently down $25.3M
[-] 110d ago
Trimmed 809.1K shares @
28.94
[+] 293d ago
Added 10.5M shares @
27.72
[+] 202d ago
Added 289.4K shares @
28.22
[+] 293d ago
Initial 8.4M shares @
27.72
Thesis
Go back
Point72
@point72-...
Bought PFE
Shares
down -2.27%
At 27.72, Now 26.3
Trims & Adds
[] Currently down $556.6K
[-] 110d ago
Trimmed 236.2K shares @
28.94
[-] 202d ago
Trimmed 40.9K shares @
28.22
[+] 293d ago
Initial 886.4K shares @
27.72
Thesis
Go back
Earl
@earl-blu...
Bought PFE
Shares
down -4.92%
At 27.66, Now 26.3
Thesis
Go back
John
@john-boo...
Bought PFE
Shares
down -11.09%
At 29.58, Now 26.3
Thesis
Go back
John
@John B
Bought PFE
Shares
down -4.81%
At 27.63, Now 26.3
Buying PFE now capitalizes on its strong pipeline of new drugs and COVID-19 vaccine sales, promising substantial future returns and potential dividend...
Read
More
Thesis
Buying PFE now capitalizes on its strong pipeline of new drugs and COVID-19 vaccine sales, promising substantial future returns and potential dividend growth, making it a sound long-term investment.
Go back
Carol
@carol-mi...
Bought PFE
Shares
down -36.09%
At 41.15, Now 26.3
Thesis
Go back
Two
@two-sigm...
Bought PFE
Shares
up 17.09%
At 43.76, Exited 51.24
Thesis
Go back
Thomas
@thomas-t...
Bought PFE
Shares
down -23.18%
At 49.8, Exited 27.65
Trims & Adds
[] Lost $13.9K on the trade
[-] 218d ago
All out @
27.65
[+] 309d ago
Added 536.86 shares @
27.94
[+] 1.4y ago
Added 415.86 shares @
36.07
[+] 1.5y ago
Added 413.00 shares @
36.32
[+] 2.9y ago
Initial 301.20 shares @
49.80
Thesis
Go back
